Tahir Amin Speaks to NDTV About the Recent Victory Against Abbott Laboratories HIV Drug Patent
WTO, WIPO and WHO Examine Role of Patent Information in Access to Medicines
Drug company’s loss could be Africa’s gain
India rejects US company’s patent for anti-HIV drugs
Top 5 Global Health Headlines: India Rejects HIV Patent
India has rejected a patent application for Abbott’s HIV/AIDS treatment Kaletra, reigniting a debate over the country’s patent rules.
Indian Government Rejects Abbott’s Patent Application For Second-Line ARV
HIV Drug to Be Distributed Worldwide
Patent On AIDS Medicine Denied In India; Seen Unlocking Market
India rejects US firms patent for anti-HIV drugs